FinancialBuzz.com’s latest Behind the Buzz Show: Featuring Our Corporate Overview on Nemaura Medical, Inc.
Nemaura Medical, Inc. (NASDAQ: NMRD) evolved from a microsystem-based drug delivery platform that was developed in 2011. Since then, we have expanded the platform to allow the monitoring of multiple chemicals in the blood, without using needles.
Replacing traditional invasive methods of diagnosis and healthcare observation procedures, our BEAT® technology will allow for remote continuous monitoring of chronic diseases and health conditions.
Nemaura has combined our in-house diagnostic platform technology and artificial intelligence (AI) development capabilities with digital healthcare platforms through partnerships. We are positioning ourselves to become a significant player in the digital healthcare revolution through our technology offerings that will combine AI, devices, and digital platforms.
For more information, please visit: Nemaura Medical, Inc.